表紙
市場調查報告書

Omeprazole的全球市場預測:2027年

Global Omeprazole Market Outlook 2027

出版商 Research Nester 商品編碼 940306
出版日期 內容資訊 英文 104 Pages
商品交期: 最快1-2個工作天內
價格
Omeprazole的全球市場預測:2027年 Global Omeprazole Market Outlook 2027
出版日期: 2020年05月01日內容資訊: 英文 104 Pages
簡介

全球Omeprazole市場在2019年∼2027年的在預測期間內,預計將以年複合成長率約6%的成長預測。

本報告提供全球Omeprazole市場相關調查分析,提供市場概要,市場動態,各市場區隔的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 報告概要

第2章 Omeprazole市場簡介

  • Omeprazole市場結構
  • Omeprazole市場定義
  • 全球Omeprazole市場分類
  • 全球Omeprazole市場概述
  • 全球Omeprazole市場動態

第3章 全球Omeprazole市場:各劑型

  • 簡介
  • 全球Omeprazole市場規模與預測:各劑型
    • 膠囊
    • 錠劑
    • 粉末

第4章 全球Omeprazole市場:各流通管道

  • 簡介
  • 全球Omeprazole市場規模與預測:各流通管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第5章 全球Omeprazole市場:各適應症

  • 簡介
  • 全球Omeprazole市場規模與預測:各適應症
    • 十二指腸潰瘍
    • 胃潰瘍
    • 胃食道逆流
    • 傳單n性食道炎
    • 其他

第6章 全球Omeprazole市場:各地區

  • 簡介
  • 全球Omeprazole市場規模與預測:各地區
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東·非洲

第7章 北美的Omeprazole市場分析與預測

  • 簡介
    • 北美
  • 北美的Omeprazole市場預測:各國
  • 北美的Omeprazole市場預測:各劑型
  • 北美的Omeprazole市場預測:各流通管道
  • 北美的Omeprazole市場預測:各適應症

第8章 南美的Omeprazole市場分析與預測

  • 簡介
    • 南美
  • 南美的Omeprazole市場預測:各國
  • 南美的Omeprazole市場預測:各劑型
  • 南美的Omeprazole市場預測:各流通管道
  • 南美的Omeprazole市場預測:各適應症

第9章 歐洲的Omeprazole市場分析與預測

  • 簡介
    • 歐洲
  • 歐洲的Omeprazole市場預測:各國
  • 歐洲的Omeprazole市場預測:各劑型
  • 歐洲的Omeprazole市場預測:各流通管道
  • 歐洲的Omeprazole市場預測:各適應症

第10章 亞太地區的Omeprazole市場分析與預測

  • 簡介
    • 亞太地區
  • 亞太地區的Omeprazole市場預測:各國
  • 亞太地區的Omeprazole市場預測:各劑型
  • 亞太地區的Omeprazole市場預測:各流通管道
  • 亞太地區的Omeprazole市場預測:各適應症

第11章 中東·非洲的Omeprazole市場分析與預測

  • 簡介
    • 中東·非洲
  • 中東·非洲的Omeprazole市場預測:各國
  • 中東·非洲的Omeprazole市場預測:各劑型
  • 中東·非洲的Omeprazole市場預測:各流通管道
  • 中東·非洲的Omeprazole市場預測:各適應症

第12章 企業簡介

  • ASTRAZENECA PLC
  • SANDOZ INTERNATIONAL GMBH
  • MYLAN N.V.
  • APOTEX, INC
  • DR. REDDY'S LABORATORIES INC
  • IMPAX LABORATORIES, INC
  • PERRIGO COMPANY PLC
  • SALIX PHARMACEUTICALS, INC
  • ALLERGAN PLC

第13章 簡稱

目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

Omeprazole is usually prescribed as proton pump inhibitor (PPI), which helps to reduce acidity. It is mainly used for the treatment of heartburn as well as for the symptoms related to gastroesophageal reflux disease. Omeprazole is also widely used as a combination drug with antibiotics like amoxicillin and clarithromycin for the treatment of ulcers caused by H. pylori bacteria. The global omeprazole market is anticipated to achieve a CAGR of around 6% during the forecast period, i.e. 2019-2027. Factors such as growing prevalence of acid refluxes, respiratory disorders, heart-related issues and others amongst the growing number of elderly populations, increasing opportunities generated from the increasing focus on innovation and development for low-cost generics by the pharmaceutical manufacturers and rising number of obese people globally are anticipated to contribute towards the growth of the global omeprazole market. Additionally, factors such as increasing awareness for the treatment of several gastrointestinal disorders amongst individuals, coupled with the rising number of patients who are suffering from peptic ulcers are some of the factors anticipated to drive the growth of the global omeprazole market.

The global omeprazole market consists of various segments that are segmented by dosage form, distribution channel, indication and by region. The distribution channel segment is further sub-divided into hospital, retail and online. Out of these, the hospital segment, which had a market value of around USD 900 million in the year 2018 is anticipated to hold the largest market share by the end of 2027 and cross a value of around USD 1500 million by growing at a CAGR of around 6.5% over the forecast period.

Based on region, the global omeprazole market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which had a value of around USD 420 million in the year 2018 is anticipated to grow at a moderate pace over the forecast period and cross a value of around USD 770 million by the end of 2027.

Some of the affluent industry leaders in the global omeprazole market are: Dr. Reddy's Laboratories Ltd., AstraZeneca plc, Sandoz International GmbH, Mylan N.V., Apotex, Inc., Amneal Pharmaceuticals LLC, Perrigo Company plc, Salix Pharmaceuticals and Allergan plc.

TABLE OF CONTENTS

1. Report Overview

  • 1.1. Global Omeprazole Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Key Questions Answered by This Analytical Report
  • 1.5. Who is This Report For?
  • 1.6. Methodology
    • 1.6.1. Primary Research
    • 1.6.2. Secondary Research
    • 1.6.3. Market Evaluation & Forecasting Methodology

2. Introduction to the Omeprazole Market

  • 2.1. Omeprazole Market Structure
  • 2.2. Omeprazole Market Definition
  • 2.3. Global Omeprazole Market Taxonomy
  • 2.4. Global Omeprazole Market Snapshot
  • 2.5. Global Omeprazole Market Dynamics
    • 2.5.1. Global Omeprazole Market: Driver
    • 2.5.2. Global Omeprazole Market: Restraints
    • 2.5.1. Global Omeprazole Market: Trends
    • 2.5.1. Global Omeprazole Market: Opportunities

3. Global Omeprazole Market, By Dosage Form, 2019-2027

  • 3.1. Introduction
  • 3.2. Global Omeprazole Market Size and Forecast, By Dosage Form
    • 3.2.1. Capsule Segment
    • 3.2.2. Tablet Segment
    • 3.2.3. Powder Segment

4. Global Omeprazole Market, By Distribution Channel, 2019-2027

  • 4.1. Introduction
  • 4.2. Global Omeprazole Market Size and Forecast, By Distribution Channel
    • 4.2.1. Hospital Pharmacies Segment
    • 4.2.2. Retail Pharmacies Segment
    • 4.2.3. Online Pharmacies Segment

5. Global Omeprazole Market, By Indication, 2019-2027

  • 5.1. Introduction
  • 5.2. Global Omeprazole Market Size and Forecast, By Indication
    • 5.2.1. Duodenal Ulcer Segment
    • 5.2.2. Gastric Ulcer Segment
    • 5.2.3. Gastroesophageal Reflux Disease Segment
    • 5.2.4. Erosive Esophagitis Segment
    • 5.2.5. Others Segment

6. Global Omeprazole Market, By Region, 2019-2027

  • 6.1. Introduction
  • 6.2. Global Omeprazole Market Size and Forecast, By Region
    • 6.2.1. North America
    • 6.2.2. Latin America
    • 6.2.3. Europe
    • 6.2.4. Asia Pacific
    • 6.2.5. Middle East and Africa

7. North America Omeprazole Market Analysis and Forecast, 2019-2027

  • 7.1. Introduction
    • 7.1.1. North America
  • 7.2. North America Omeprazole Market Forecast, By Country, 2019-2027
  • 7.3. North America Omeprazole Market Forecast, By Dosage Form, 2019-2027
  • 7.4. North America Omeprazole Market Forecast, By Distribution Channel, 2019-2027
  • 7.5. North America Omeprazole Market Forecast, By Indication, 2019-2027

8. Latin America Omeprazole Market Analysis and Forecast, 2019-2027

  • 8.1. Introduction
    • 8.1.1. Latin America
  • 8.2. Latin America Omeprazole Market Forecast, By Country, 2019-2027
  • 8.1. Latin America Omeprazole Market Forecast, By Dosage Form, 2019-2027
  • 8.2. Latin America Omeprazole Market Forecast, By Distribution Channel, 2019-2027
  • 8.3. Latin America Omeprazole Market Forecast, By Indication, 2019-2027

9. Europe Omeprazole Market Analysis and Forecast, 2019-2027

  • 9.1. Introduction
    • 9.1.1. Europe
  • 9.2. Europe Omeprazole Market Forecast, By Country, 2019-2027
  • 9.3. Europe Omeprazole Market Forecast, By Dosage Form, 2019-2027
  • 9.4. Europe Omeprazole Market Forecast, By Distribution Channel, 2019-2027
  • 9.5. Europe Omeprazole Market Forecast, By Indication, 2019-2027

10. Asia Pacific Omeprazole Market Analysis and Forecast, 2019-2027

  • 10.1. Introduction
    • 10.1.1. Asia Pacific
  • 10.2. Asia Pacific Omeprazole Market Forecast, By Country, 2019-2027
  • 10.3. Asia Pacific Omeprazole Market Forecast, By Dosage Form, 2019-2027
  • 10.4. Asia Pacific Omeprazole Market Forecast, By Distribution Channel, 2019-2027
  • 10.5. Asia Pacific Omeprazole Market Forecast, By Indication, 2019-2027

11. Middle East & Africa Omeprazole Market Analysis and Forecast, 2019-2027

  • 11.1. Introduction
    • 11.1.1. MEA
  • 11.2. MEA Omeprazole Market Forecast, By Country, 2019-2027
  • 11.3. MEA Omeprazole Market Forecast, By Dosage Form, 2019-2027
  • 11.4. MEA Omeprazole Market Forecast, By Distribution Channel, 2019-2027
  • 11.5. MEA Omeprazole Market Forecast, By Indication, 2019-2027

12. Company Profiles

  • 12.1. ASTRAZENECA PLC
    • 12.1.1. Overview
    • 12.1.2. Product Type/Service Offerings
    • 12.1.3. Key Developments
    • 12.1.4. SWOT Analysis
  • 12.2. SANDOZ INTERNATIONAL GMBH
    • 12.2.1. Overview
    • 12.2.2. Product Type/Service Offerings
    • 12.2.3. Key Developments: NA
    • 12.2.4. SWOT Analysis
  • 12.3. MYLAN N.V.
    • 12.3.1. Overview
    • 12.3.2. Product Type/Service Offerings
    • 12.3.3. Key Developments: NA
    • 12.3.4. SWOT Analysis
  • 12.4. APOTEX, INC
    • 12.4.1. Overview
    • 12.4.2. Product Type/Service Offerings
    • 12.4.3. Key Developments: NA
    • 12.4.4. SWOT Analysis
  • 12.5. DR. REDDY'S LABORATORIES INC
    • 12.5.1. Overview
    • 12.5.2. Product Type/Service Offerings
    • 12.5.3. Key Developments
    • 12.5.4. SWOT Analysis
  • 12.6. IMPAX LABORATORIES, INC
    • 12.6.1. Overview
    • 12.6.2. Product Type/Service Offerings
    • 12.6.3. Key Developments: NA
    • 12.6.4. SWOT Analysis
  • 12.7. PERRIGO COMPANY PLC
    • 12.7.1. Overview
    • 12.7.2. Product Type/Service Offerings
    • 12.7.3. Key Developments
    • 12.7.4. SWOT Analysis
  • 12.8. SALIX PHARMACEUTICALS, INC
    • 12.8.1. Overview
    • 12.8.2. Product Type/Service Offerings
    • 12.8.3. Key Developments: NA
    • 12.8.4. SWOT Analysis
  • 12.9. ALLERGAN PLC
    • 12.9.1. Overview
    • 12.9.2. Product Type/Service Offerings
    • 12.9.3. Key Developments: NA
    • 12.9.4. SWOT Analysis

13. Acronyms